@article{Yanagisawa2020,
 abstract = {\textlessp\textgreaterIt is known that single or isolated tumor cells enter cancer patients' circulatory systems. These circulating tumor cells (CTCs) are thought to be an effective tool for diagnosing cancer malignancy. However, handling CTC samples and evaluating CTC sequence analysis results are challenging. Recently, the convolutional neural network (CNN) model, a type of deep learning model, has been increasingly adopted for medical image analyses. However, it is controversial whether cell characteristics can be identified at the single-cell level by using machine learning methods. This study intends to verify whether an AI system could classify the sensitivity of anticancer drugs, based on cell morphology during culture. We constructed a CNN based on the VGG16 model that could predict the efficiency of antitumor drugs at the single-cell level. The machine learning revealed that our model could identify the effects of antitumor drugs with Ìƒ0.80 accuracies. Our results show that, in the future, realizing precision medicine to identify effective antitumor drugs for individual patients may be possible by extracting CTCs from blood and performing classification by using an AI system.\textless/p\textgreater},
 author = {Yanagisawa, Kiminori and Toratani, Masayasu and Asai, Ayumu and Konno, Masamitsu and Niioka, Hirohiko and Mizushima, Tsunekazu and Satoh, Taroh and Miyake, Jun and Ogawa, Kazuhiko and Vecchione, Andrea and Doki, Yuichiro and Eguchi, Hidetoshi and Ishii, Hideshi},
 doi = {10.3390/ijms21093166},
 issn = {1422-0067},
 journal = {International Journal of Molecular Sciences},
 month = {apr},
 number = {9},
 pages = {3166},
 title = {Convolutional Neural Network Can Recognize Drug Resistance of Single Cancer Cells},
 url = {https://www.mdpi.com/1422-0067/21/9/3166},
 volume = {21},
 year = {2020}
}

